Human coagulation factor VIII (CSL Ltd)

人凝血因子VIII（CSL Behring）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman coagulation factor VIII (CSL Ltd)

Drug Alias NameCSL 650CSL-626 rD'D3 FPCSL 626

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCsl Behring Llc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCsl Behring Llc

Active IndicationsN/A

Inactive IndicationsHemophilia A

ATC CodeN/A